Risk Management



Removal of abnormal cells from eye surface

Removal of abnormal cells from surface of eye consent form can be used when treating OSSN (ocular surface squamous neoplasia) and CIN (conjunctival intraepithelial neoplasia). It is written in plain language to make it easier for patients to understand.

We thank OMIC Director Steven I. Rosenfeld, MD, for his assistance in developing this form.

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

#2. Leader in the industry.

A-rated by AM Best, OMIC is ranked #1 among 50 malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined and operating ratios, the two most relevant financial measurements for an insurance carrier.

61864684